Skip to main content
Intensive Care Medicine Experimental logoLink to Intensive Care Medicine Experimental
. 2020 Aug 14;8:44. doi: 10.1186/s40635-020-00332-0

Cerebral autoregulation and neurovascular coupling are progressively impaired during septic shock: an experimental study

Lorenzo Ferlini 1,, Fuhong Su 2, Jacques Creteur 2, Fabio Silvio Taccone 2, Nicolas Gaspard 1
PMCID: PMC7426896  PMID: 32797301

Abstract

Background

Alteration of the mechanisms of cerebral blood flow (CBF) regulation might contribute to the pathophysiology of sepsis-associated encephalopathy (SAE). However, previous clinical studies on dynamic cerebral autoregulation (dCA) in sepsis had several cofounders. Furthermore, little is known on the potential impairment of neurovascular coupling (NVC) in sepsis. The aim of our study was to determine the presence and time course of dCA and NVC alterations in a clinically relevant animal model and their potential impact on the development of SAE.

Methods

Thirty-six anesthetized, mechanically ventilated female sheep were randomized to sham procedures (sham, n = 15), sepsis (n = 14), or septic shock (n = 7). Blood pressure, CBF, and electrocorticography were continuously recorded. Pearson’s correlation coefficient Lxa and transfer function analysis were used to estimate dCA. NVC was assessed by the analysis of CBF variations induced by cortical gamma activity (Eγ) peaks and by the magnitude-squared coherence (MSC) between the spontaneous fluctuations of CBF and Eγ. Cortical function was estimated by the alpha-delta ratio. Wilcoxon signed rank and rank sum tests, Friedman tests, and RMANOVA test were used as appropriate.

Results

Sepsis and sham animals did not differ neither in dCA nor in NVC parameters. A significant impairment of dCA occurred only after septic shock (Lxa, p = 0.03, TFA gain p = 0.03, phase p = 0.01). Similarly, NVC was altered during septic shock, as indicated by a lower MSC in the frequency band 0.03–0.06 Hz (p < 0.001). dCA and NVC impairments were associated with cortical dysfunction (reduction in the alpha-delta ratio (p = 0.03)).

Conclusions

A progressive loss of dCA and NVC occurs during septic shock and is associated with cortical dysfunction. These findings indicate that the alteration of mechanisms controlling cortical perfusion plays a late role in the pathophysiology of SAE and suggest that alterations of CBF regulation mechanisms in less severe phases of sepsis reported in clinical studies might be due to patients’ comorbidities or other confounders. Furthermore, a mean arterial pressure targeting therapy aiming to optimize dCA might not be sufficient to prevent neuronal dysfunction in sepsis since it would not improve NVC.

Keywords: Sepsis, Septic shock, Sepsis-associated encephalopathy, Cerebrovascular microcirculation, Neurovascular coupling, Brain dysfunction

Introduction

Sepsis-associated encephalopathy (SAE) is defined as cerebral dysfunction that accompanies sepsis in the absence of direct central nervous system infection, structural abnormality, or other causes of encephalopathy [1]. Although mostly reversible, SAE is associated with higher short-term mortality [2] and long-term cognitive impairment among survivors [3]. While its physiopathology is not completely understood [1], in addition to a BBB dysfunction [46], several studies suggested alterations of cerebral blood flow (CBF) regulation mechanisms as key factors for SAE [711]. Post-mortem studies found widespread ischemic lesions in the brain in septic patients, supporting the role of inadequate cerebral perfusion in SAE [12, 13].

Since brain tissue has a high metabolic demand without efficacious system of substrate storage, CBF is strictly controlled to ensure adequate energy supply [14]. CBF is determined by cerebral perfusion pressure (CPP, i.e., the differential between the mean arterial pressure (MAP) and the intracranial pressure), cardiac output, and the vascular tone of the small cerebral vessels [15]. In response to variations of CPP, an adaptation of vascular resistance allows CBF to remain stable, a mechanism known as cerebral autoregulation (CA) [16]. It was originally found that CBF remains constant over a wide range of CPP changes (static cerebral autoregulation, sCA) [16]. Later studies showed that, in that range of CPP values, cerebrovascular autoregulatory capacity depended on the direction (increase vs. decrease) and the speed of changes in CPP [17, 18]. The quantification of fast modifications in cerebrovascular resistance, and consequently in CBF, in relation to rapid changes in MAP within the range of sCA is referred to as “dynamic CA” (dCA). Clinical studies have found alteration of CA in sepsis, especially in the presence of SAE, but they had several confounders: use of vasopressors, variable CO2 arterial pressure (PaCO2) or temperature, history of hypertension, age, or the presence of extra-cerebral organ dysfunction [8, 9, 19, 20]. Moreover, previous studies included patients with different diseases severity (sepsis and septic shock [21]) evaluated at a variable interval after sepsis diagnosis (between 24 to 72 h) and using different methods (time [8, 9, 20] vs. frequency domain [19]). It is thus still unclear to which extent CA is altered by sepsis itself and which is the temporal course of its disruption.

CBF is also regulated by neuronal activity. This neurovascular coupling (NVC) is responsible for the fine regulation of oxygen and glucose delivery in response to increase in neuronal activity [22]. Whereas previous studies assessed NVC in stimuli-induced conditions both in septic patients and animal models [22, 23], little is known about NVC during spontaneous cerebral activity, which represents most of cerebral activity in mechanically ventilated sedated patients and lends itself more easily to monitoring. Similarly to CA, important confounders, such as age and extra-cerebral organ dysfunction, were not completely accounted for in these studies [22].

The primary aim of this study was thus to determine the time course of alterations of CA and NVC in a clinically relevant animal sepsis model. Our secondary aim was to determine the presence and time course of the associated cortical dysfunction.

Materials and methods

General procedure

The Institutional Review Board for Animal Care of the Free University of Brussels (Belgium) approved all experimental procedures (number of Ethical Committee approval: 675 N), which were also in compliance with ARRIVE (Animal Research: Reporting in Vivo Experiments) guidelines. Care and handling of the animals were in accord with National Institutes of Health guidelines (Institute of Laboratory Animal Resources). The protocol was performed on forty female Ovis Aries sheep. We initially planned to allocate animals with a 1:1:1 ratio in the septic (n = 16), septic shock (n = 16), or sham groups (n = 16). For ethical reasons, in order to limit the number of animals, interim analyses were carried out. This allowed reducing the number of animals in the septic shock group to 8. Sample sizes were based on previous studies from our laboratory using the same animal model [7, 24]. After randomization, animals were excluded if they presented a hemoglobin level below 8 g/dl or systemic signs of infection at the moment of the delivery to the laboratory. The general procedures have been described previously [7]; a detailed version is available as Additional Content. Briefly, sheep were mechanically ventilated under general anesthesia provided by continuous IV infusion of ketamine, morphine, and midazolam. Initial doses (ketamine 20 mg kg−1 h−1; morphine 2 mg kg−1 h−1; midazolam 3 mg kg−1 h−1) were adjusted according to electrocorticography (ECOG) in order to achieve a nearly continuous background (i.e., the fraction of ECOG spent in suppression [amplitudes < 10 μV for ≥ 5 s] < 10%). Muscular blockade was achieved using 10 μg.kg−1.h−1 of rocuronium.

Surgical procedure

In the sepsis group animals, a midline laparotomy was performed to allow cecum exposure; cecotomy was realized for feces collection (1.5 g.kg−1 of body weight), and after local disinfection with iodine solution, the cecum was closed with a double suture and returned to the abdominal cavity. A 25-cm plastic tube (Beldico SA, Marche-En-Famenne, Belgium) was inserted through the laparotomy incision in the abdominal cavity for successive feces injection and secured to the abdominal wall which was successively sutured in two layers. In the sham group, laparotomy was performed in order to provide a systemic post-surgical inflammatory response similar to the sepsis group while avoiding the risk of infection. The animal was then turned in the prone position for the brain surgical procedure. Bilateral craniotomy was performed using a high-speed drill (Wuhu Ruijin Medical instrument, Wuhu, China), and two 2.5 cm2 bone holes were opened in the frontal-parietal bones, one on each side, using a laminectomy tool (Aesculap-WerkeAG, Tuttlingen, Germany). The dura mater was opened with scissors, and two 4-contact ECOG electrodes (Dixi Medical, Besançon, France), one per hemisphere, were slipped beneath the dura over the cortex surface of the post-central gyrus and taped to the skull. At a distance of 0.5 cm from the ECOG electrodes, the dura mater was subsequently punctured to insert a laser Doppler flowmetry probe (OxyFlow 4000, Oxford Optronic, UK) for local cerebral blood flow velocity (CBFv) measurement. All catheters were placed under sterile conditions at a depth of 0.5 cm into the brain parenchyma as close as possible one to each other.

Monitoring and measurements

Ventilator parameters were adjusted to maintain PaO2 between 90 and 120 mmHg (12–16 kPa) and PaCO2 between 30 and 45 mmHg (4–6 kPa) (as hypercapnia negatively influence CA in sepsis [10]), according to repeated blood gas analysis (Cobas b123, Roche diagnostic, Rotkreuz, Switzerland). Cardiac output and systemic and pulmonary arterial pressure were invasively and continuously measured and recorded simultaneously with ECOG and CBFv with a sampling rate of 250 Hz (Notocord-hem, Instern Company, France). Measurements of mean pulmonary arterial pressure were collected every 1.5 h. Cardiac index (CI) was calculated using standard formulas; the body surface area was estimated from Mitchell’s sheep-specific formula [25].

Experimental protocol

After the surgical procedures, the animal was allowed to stabilize for 1 h. In all groups, plasmalyte solution and 6% hydroxy-ethyl starch solution (Voluven; Fresenius Kabi, Schelle, Belgium) were titrated to prevent hypovolemia and arterial hypotension.

Sepsis vs. sham groups

In the sepsis group, feces were injected into the abdominal cavity, and animals were observed until septic shock (SS) occurred, defined as persisting MAP < 65 mmHg and lactate elevation > 2 mmol/L despite adequate fluid resuscitation [21]; then, animals were sacrificed using IV potassium chloride. From our previous experiences with this model, we saw that after septic shock, the respiratory parameters are difficult to be controlled without a timing vasopressor therapy; since PaCO2 highly influences cerebrovascular resistance and dCA assessment, animals in the sepsis group were sacrificed after septic shock. In the sham group, data were collected for 12.5 h; then, animals were sacrificed using IV potassium chloride. All analyses were performed offline, using built-in functions and custom scripts in Matlab (The MathWorks, Natick, MA, USA). Since the interval to develop septic shock differed between septic animals, data from sepsis and sham animals were subdivided into four equal time epochs. The first 30 min for each epoch were selected, and they represented the first four time points (T1sepsis–T4sepsis); the fifth time point (T5sepsis) corresponds to the last 30 min of the whole recording. The same set of analysis was performed for each time point in all animals.

Septic shock group

In the septic shock (SS) group, after the initial stabilization period, feces were injected in the abdominal cavity as in the sepsis group. When the response to fluids resuscitation became insufficient, noradrenaline (NA) was started (initial dose 0.5 μg/kg/min) and adjusted to maintain MAP around 80 mmHg. The response to fluid challenge (250 cc infused in 10 min) was deemed insufficient when it resulted in a rise in the CO inferior to 15% of the pre-challenge value [26]. The infusion of NA was maintained and titrated up until the MAP did no longer respond to increase in NA dose and fell below 65 mmHg. Data during NA infusion were subdivided into four time epochs, and four time points (T1SS–T4SS) were identified by selecting the first 30 min for each epoch; in addition, two 30-min time epochs were selected, one immediately before the onset of the NA infusion (T0SS) and the second immediately after NA withdrawal (T5SS). Since the end of the recording in the sepsis group slightly differed from the beginning of NA infusion in the septic shock animals, data collected before T0SS were discarded for purpose of rigor.

Data analysis

Data pre-processing

Physiologically implausible values (MAP > 250 mmHg or < 0 mmHg; CBFv > 5000 blood perfusion units (BPU) or < 100 BPU; CO > 15 L/min or < 0 L/min) and artifacts were visually removed, prior to further analysis.

Dynamic cerebral autoregulation (dCA)

CBFv signals from the 2 hemispheres were averaged, yielding a mean-CBFv (mCBF). For dCA assessment, 2 linear methods, one in the time domain (Lxa) and the other in the time-frequency domain (transfer function analysis, TFA), were employed using recorded spontaneous fluctuations of MAP and mCBF.

For Lxa, MAP and mCBF were further averaged on 10 s consecutive windows without overlap; then, a Pearson’s correlation coefficient between 30 samples of the averaged values was calculated. Lxa can take any value between − 1 and 1. Values close to 1 indicate linear correlation between variables and thus poor autoregulation whereas values closer to 0, or negative, indicate good autoregulation [27]. In contrast to the previously published Lx index [28, 29], obtained with CPP instead of MAP, Lxa index has never been validated in animal or human studies; as a consequence, no cutoff values are available to define autoregulatory failure. On the other hand, a close association was found between the two laser-flow-Doppler derived methods, Lx and Lxa, and it has been previously shown in our model [7] that CPP variations are superimposable to MAP ones since intracranial pressure do not present notable changes.

We used TFA (Matlab TFA function provided by the Cerebral Autoregulation Research Network [30]) to estimate the gain and the phase shift in the very low frequency range (VLF, 0.02 < Hz < 0.07), where dCA is supposed to be more efficient [31, 32]. Parameters for TFA were window length of 102.4 s, with 59.9% overlap and a Hanning window that led to 41 windows and a spectral resolution of 0.009 Hz. Also, each window contained at least one full period oscillation of the lower frequency considered (0.02 Hz).

Neurovascular coupling

The methodological steps are summarized in Fig. 1. CBFv from both hemispheres was filtered using a low-pass zero-phase fourth-order Butterworth filter with a cut-off frequency of 0.25 Hz to limit the higher frequency hemodynamics fluctuations (i.e., due to breathing) [33]. The envelope of the high gamma frequency band (Eγ), a measure of neuronal cortical activity driving NV C[34], was extracted from the ECOG signal using wavelet transform spectral density estimate (cwt, icwt, and envelope functions in Matlab). Neurovascular coupling was subsequently measured using two different approaches. First, NVC driven by spikes of cortical activity was assessed. Briefly, Eγ envelope peaks which exceeded one standard deviation above the mean [35] were detected (findpeaks function in Matlab). For each detected Eγ activity peak, CBFv epochs spanning from 5 s before to 15 s after the peak were selected, detrended (detrend function in Matlab), and normalized using the mean and standard deviation calculated on the 5 s pre-Eγ peak epoch. If a CBFv peak was identified following the Eγ peak (findpeaks function in Matlab), the CBF epoch was included for further analysis. For each included CBFv peak, the normalized amplitude and lag from the corresponding Eγ peak were calculated. We also assessed the spontaneous fluctuations of Eγ (second-level spectrogram) and CBFv with Welch’s periodogram, with an epoch length of 30 min, a window length 180 s, and a window overlap 90%. Previous studies reported that the main peaks of the alpha and theta EEG second-level spectrum were located between 0.01 and 0.02 Hz, between 0.05 and 0.07 Hz, and between 0.1 and 0.25 Hz [3638]. Since gamma band oscillates with a similar periodicity [39], these frequency bands were used for ECOG second-level spectrum analysis. For CBFv fluctuations, the following frequency subcomponents where used, according to the literature: from 0.02 to 0.04 and from 0.04 to 0.15 [40, 41]. The coherence between Eγ signal and the filtered, detrended and normalized CBFv was then measured by MSC, using the same parameters as for the second-level periodogram. Since the literature does not provide any, we identified peaks in the MSC spectrum of early sham animals (Supplemental Figure S1) and identified their frequency boundaries (0.03 to 0.06 Hz and 0.06 to 0.13 Hz) and used them for further analysis.

Fig. 1.

Fig. 1

Schematic of analysis techniques used to identify neural events for selecting epochs of the accompanying hemodynamics. Magnification of the gamma filtered EEG signal and the corresponding envelope (Eγ) of a peak of neuronal activity (top row). A 45 s Eγ trial from a single animal is shown as an example (middle row); two peaks of neuronal activity above the chosen threshold are marked. A time epoch of 20 s around the first peak is drawn. Corresponding 45 s of CBFv fluctuation from the same animal (bottom row); an increase in the CBFv appears few seconds after the Eγ peak

Alpha-delta ratio

For each time point described above, ECOG spectrograms were calculated using the Welch’s method. The alpha-delta ratio (ADR) was further calculated, as the ratio between power in the alpha (4–8 Hz) and delta (0.5–4 Hz) frequency bands.

Statistical analyses

Statistical analyses were performed using Matlab (The MathWorks, Natick, MA, USA). A p value < 0.05 was considered statistically significant. The sepsis group was compared to the sham group. In the septic shock group, each animal served as its own control; analyses were performed between time points during NA infusion. While NA is known to affect dCA, this effect is lost in case of sepsis [42]. Consequently, it would have been misleading to compare septic animals under NA infusion with sham animals without vasopressors. This also allowed reducing the number of animals.

The Kolmogorov-Smirnov test was performed to assess the normal distribution of values. Data are presented as median and interquartile range (IQR) or median and median absolute deviation. Wilcoxon signed rank test and Friedman test were used to analyze variable differences in time within single groups, Wilcoxon rank sum test, and two-way repeated-measure ANOVA for differences between groups, as appropriate; the linear step-up procedure introduced by Benjamini and Hochberg was applied for controlling the false discovery rate [43]. Tukey-Kramer and Holm post-hoc analysis were employed in case of a corrected p value < 0.05.

Since a low MSC could be the result of a noisy signal [44], a cut-off value is necessary to avoid unreliable estimations of gain and phase using the TFA method [45]. The MSC thresholds for a specific frequency were calculated using a Monte Carlo simulation (95% confidence interval based on 100 repetitions of MSC estimation of randomly values adopting standardized parameters recommended in [45] and specified before). In case of non-significant coherence, corresponding gain and phase values were excluded from analysis. Similarly, the coherence between Eγ and CBFv in the assessment of NVC was considered statistically significant if its value for a specific frequency was greater than 95% confidence limit calculated by a Monte Carlo simulation.

Results

Thirty-six female sheep were included in the protocol (weight, 25 kg [interquartile range (IQR) 22–31]); 4 animals were excluded (Hb < 8 g/dl, n = 1 in the septic shock group; systemic signs of infection, n = 3, two in the sepsis group and one in the sham group). In sepsis animals (n = 14), SS occurred after a median interval of 12.5 h [IQR, 10–13.4 h]; in the sham group (n = 15), data were collected for 12.5 h. In septic shock group (n = 7), the median interval from the beginning of the experiment to the NA infusion was 14.9 h [IQR, 12–15.1 h]; data were collected for a median of 33.5 h [IQR, 29.7–33.8 h], until spontaneous death occurred.

Systemic parameters

Evolution of systemic hemodynamics, respiratory, and biological variables over time in the sepsis and the sham animals are presented in Table 1. A significant increase in cardiac index marked the onset of the hyperdynamic state of sepsis and was associated with increase in lactatemia and reduction in the Pa/FiO2 ratio.

Table 1.

Evolution of systemic hemodynamic, respiratory, and biological parameters in sepsis (n = 14) and sham (n = 15) animals

Variables Group Time point 1sepsis Time point 2sepsis Time point 3sepsis Time point 4sepsis Time point 5sepsis ANOVA group * time (p)
T (°C) Sepsis 38.8 (38–40) 39.5 (38.7–40.6) 40.1 (39–40.8) 40.3 (38.6–40.6) 40.1 (38.4–40.4) 0.70
Sham 40.0 (39.7–40.3) 40.5 (39.9–40.7) 40.7 (40.3–40.8) 40.5 (40.3–40.7) 40.7 (40.2–41)
CI (l/min/m2) Sepsis 1.8 (1.4–2.3) 2.1 (1.5–2.7) 2.6 (1.9–3.6) 2.7 (2.4–4.0)a,b 2.7 (1.8–4.0)a,b 0.049
Sham 1.8 (1.6–2.2) 2.2 (2.0–3.0) 2.4 (1.7–2.9) 2.4 (2.0–2.9) 2.1 (1.6–2.8)
MAP (mmHg) Sepsis 83 (79–90) 84 (77–90) 83 (75–94) 77 (72–80) 70 (69–72) 0.10
Sham 97 (94–103) 90 (82–97) 89 (82–89) 84 (82–94) 84 (78–94)
MPAP (mmHg) Sepsis 10 (5–12) 11 (7–13) 13(12–15) 12 (11–22) 23 (13–25) 0.13
Sham 8 (5–17) 11 (6–13) 10 (5–13) 11 (6–13) 12 (8–13)
PaO2/FiO2 Sepsis 332 (293–389) 344 (252–390) 302 (148–358) 185 (110–336)a,b 114 (74–253)a,b 0.034
Sham 372 (333–385) 365 (328–378) 346 (326–391) 350 (316–389) 335 (295–367)
PaCO2 (mmHg) Sepsis 33 (32–36) 33 (33–35) 34 (32–36) 36 (34–38) 36 (34–40) 0.22
Sham 35 (33–38) 35 (33–37) 34 (33–36) 36 (34–37) 35 (34–36)
PaO2 (mmHg) Sepsis 114 (105–126) 109 (101–127) 105 (88–116) 89 (75–112) 98 (68–109) 0.14
Sham 115 (108–126) 114 (109–125) 114 (109–122) 113 (104–121) 113 (104–121)
Hb (g/dl) Sepsis 8.0 (7.5–9) 9.2 (8.5–9.8)a 8.6 (8.2–10.3) 8.8 (8.29–9.6) 9.0 (8.0–9.7) 0.09
Sham 8.5 (7.7–9) 8.7 (7.4–9.4) 8.4 (7.4–9) 8.4 (7.1–8.7) 8.2 (7.6–9.0)
Lactate (mmol/l) Sepsis 0.5 (0–1.2) 0.6 (0.0–1.4) 1.2 (0–1.8) 1.3 (1.1–1.9)a,b 1.9 (1.1–2.4)a,b 0.002
Sham 0.0 (0–1) 0.5 (0.0–1.1) 0.0 (0–0) 0.0 (0–0) 0.0 (0–0)
pH Sepsis 7.43 (7.38–4.47) 7.45 (7.39–7.47) 7.42 (7.37–7.45) 7.40 (7.32–7.41) 7.33 (7.29–7.39) 0.14
Sham 7.45 (7.42–7.48) 7.44 (7.40–7.46) 7.41 (7.35–7.43) 7.40 (7.34–7.41) 7.40 (7.33–7.41)
Urine output (ml) Sepsis 0 (0–0) 250 (125–345) 459 (200–560) 721 (300–890) 691 (443–1091) 0.06
Sham 0 (0–0) 250 (141–506) 573 (408–973) 935 (593–1468) 1180 (858–1740)
Fluids amount (ml) Sepsis 800 (573–952) 1666 (888–2329) 2474 (1580–2889) 3400 (2045–4529) 4558 (2300–5616) 0.06
Sham 659 (500–1075) 1272 (820–1732) 1935 (1498–2292) 2915 (1909–3119) 3090 (1832–3434)
Midazolam (mg/kg) Sepsis 11 (10–11) 14 (13–15) 16 (15–17) 17 (17–20) 19 (18–23) 0.029
Sham 11 (10–11) 16 (13–17) 19 (17–23) 22 (20–26) 25 (22–31)
Ketamine (mg/kg) Sepsis 70 (64–70) 93 (89–99) 104 (103–116) 116 (112–134) 126 (117–150) 0.029
Sham 70 (64–70) 104 (89–116) 125 (110–150) 146 (131–176) 168 (144–204)

Data are presented as median and (IQR). In case of significant ANOVA group-time interaction, post-hoc analysis is presented. Significant at 5% vs. (a) time point 1 or (b) time point 2 in the within-group analysis. Significant differences between groups at a specific time point are bold

°C Celsius degrees, CI cardiac index, MAP mean arterial pressure, MPAP mean pulmonary arterial pressure, PaO2/FiO2 ratio used to identify and quantify acute lung injury (acute lung injury if ratio ≤ 300, acute respiratory distress syndrome if ratio ≤ 200)

Table 2 shows the evolution of the same systemic parameters during the septic shock phase. NA infusion allowed to maintain a value of MAP around 80 mmHg (median 78 mmHg; IQR, 74.5–80.4); NA total doses were similar between animals (5.1 ± 0.3 mg/kg). PaCO2 and PaO2 did not vary significantly throughout the experiment. A slight and non-significant increase in PaCO2 was observed in the late time points (T4SS) in the septic shock animals (Table 2). Nevertheless, no animal had PaCO2 values outside the normal range.

Table 2.

Evolution of systemic hemodynamics, respiratory, and biological variables over time in septic shock (n = 7) animals

Variables Time point 0SS Time point 1SS Time point 2SS Time point 3SS Time point 4SS Time point 5SS Friedman (p)
Noradrenaline Off On On On On Off NA
T (°C) 39.3 (38.1–40.3) 39.3 (38.7–40.3) 40.0 (39.6–40.7) 40.7 (40.7–40.8) 40.6 (40.1–40.8) 40.0 (39.7–41.0) < 0.001
CI (l/min/m2) 1.7 (1.5–2.3) 2.2. (1.8–2.4) 2.2 (2.2–4.0) 2.3 (2.3–3.7) 1.4 (1.0–2.6) 1.1 (0.7–2.4) 0.11
MAP (mmHg) 78 (72–80) 79 (75–81) 78 (77–83) 78 (77–80) 73 (71–79) 51 (48–55)b,c,d 0.009
MPAP (mmHg) 15 (11–17) 19 (17–23) 26 (21–29) 29 (24–33) 29 (26–32)b 30 (26–35) < 0.001
PaO2/FiO2 383 (327–399) 340 (310–378) 288 (226–302) 235 (175–292) 175 (159–223) 166 (135–199) 0.05
PaCO2 (mmHg) 35 (34–35) 35 (33–38) 37 (34–43) 37 (36–40) 39 (38–41) 38 (30–39) 0.05
PaO2 (mmHg) 114 (108–123) 104 (98–113) 91 (83–97) 105 (97–112) 106 (98–122) 104 (97–120) 0.31
Hb (g/dl) 8.7 (7.7–9.6) 9.7 (7.2–11.2) 9.9 (8–10.4) 9.6 (8.2–10.1) 7.4 (6.2–9.1) 5.5 (4.9–7.8) 0.003
Lactate (mmol/l) 1.4 (0.9–1.8) 1.6 (1.0–2.4) 2.3 (1.9–2.7) 4.8 (3.6–5.8) 6.4 (6–10) 8.7 (8.7–10.3)a,b,c,d < 0.001
pH 7.38 (7.37–7.46) 7.36 (7.34–7.38) 7.26 (7.23–7.33) 7.12 (7.04–7.28) 6.9 (6.81–7.17) 6.9 (6.77–7.02)c,d < 0.001
Midazolam(mg/kg) 29 (25–40) 36 (30–43) 44 (43–49) 57 (53–59) 59 (57–68) 60 (57–70) < 0.001
Ketamine (mg/kg) 194 (164–265) 237 (201–290) 296 (284–329) 378 (352–395) 396 (383–453) 401 (383–467) < 0.001

Data are presented as median and (IQR). Only significant post-hoc analysis is presented; the corresponding ANOVA p values are bold. Significant at 5% vs (a) time point 0SS, (b) time point 1SS, (c) time point 2SS, and (d) time point 3SS in the within-group analysis

°C Celsius degrees, CI cardiac index, MAP mean arterial pressure, MPAP mean pulmonary arterial pressure, PaO2/FiO2 ratio used to identify and quantify acute lung injury (acute lung injury if ratio ≤ 300, acute respiratory distress syndrome if ratio ≤ 200), Hb hemoglobin, SS septic shock

Cerebral autoregulation

Changes in the dCA parameters at different time points are summarized in Fig. 2. We found no difference in the Lxa or in the TFA parameters between the sepsis and sham groups. In the septic shock animals, the Lxa significantly increased between T1SS and T4SS. Upon NA withdrawal, Lxa approached unity, indicating complete loss of dCA. Both TFA parameters showed comparable trends towards a late reduction in the efficacy of dCA in the septic shock group, approximately 5 ± 1.8 h before Lxa. We found no significant correlations between dCA parameters (TFA and Lxa, p = 0.19 and p = 0.46, respectively) and PaCO2 (p = 0.27).

Fig. 2.

Fig. 2

Temporal evolution of dynamic cerebral autoregulation parameters during experimental sepsis. Lxa (a, b), TFA gain (c, d), and phase (e, f), and of mean arterial pressure (g, h) in sepsis vs. sham (a, c, e, g) and septic shock (b, d, f, h). No difference was observed between the sepsis and sham groups but a progressive increase in Lxa, TFA gain, and a progressive decrease in TFA phase was observed in the septic shock group, indicating progressive loss of dCA. N/A = not available data, due to coherence values below significance (see the “Materials and Methods” section). Data are presented as median ± mean absolute deviation. *p < 0.05; **p < 0.01

Neurovascular coupling

We found no significant difference in the percentage of Eγ peaks followed by CBFv peaks, the amplitude and lag of the CBFv peaks, between or within the sham and sepsis groups, although there was a trend towards a decrease in Eγ peaks followed by CBFv peaks in the last time point in the sepsis group (Supplemental Figure S2). Similarly, none of the parameter showed a significant change during septic shock, although there was again a decreasing trend in the percentage of Eγ peaks followed by CBFv peaks with progressing sepsis. The second-level Eγ spectrum, the periodogram of CBFv, and the MSC between Eγ and CBF did not show any significant change in the sham and sepsis groups (Supplemental Figure S3a (A,C), S3b (A,C,E), S3c (A,C)). However, we observed a significant decrease between T1SS (immediately after NA) and T4SS (last time point prior to cessation of NA) in spontaneous fluctuations of CBFv in frequencies between 0.04 and 0.15, as well as in MSC between Eγ and CBFv in frequencies between 0.03 and 0.06 Hz (Fig. 3).

Fig. 3.

Fig. 3

Temporal evolution of neurovascular coupling measured by coherence between periodic fluctuations of cortical activity and cerebral blood flow. Cerebral blood flow velocity (CBFv) spectral power (0.04–0.15 Hz frequency band; a, b), second-level spectral power of gamma activity envelope (Eγ; 0.05–0.07 Hz frequency band; c, d), and their magnitude-squared coherence (MSC; 0.03–0.06 Hz frequency band; e, f) in sepsis vs. sham groups (a, c, e) and in septic shock group (b, d, f), expressed as median and inter-quartile range. *p < 0.05 by RMANOVA test analysis. No significant difference, neither in CBFv nor in Eγ spectra fluctuations nor in MSC, was observed in sepsis and sham animals in any of the frequency bands considered. In the septic shock group, there was a significant decrease between T1SS and T4SS in the spectrum of CBFv fluctuations between 0.04 and 0.15 Hz and a significant decrease in MSC for frequencies between 0.03 and 0.06 Hz. Comparative analysis for other frequencies of CBFv and Eγ spectral power and MSC are presented in Supplemental Figure S3 (a, b, c). Power spectral density estimation are expressed in √dB/Hz

Cortical activity

Finally, as shown in Fig. 4, the alpha/delta ratio of the ECOG signal remained stable during sepsis but showed a significant decrease during septic shock.

Fig. 4.

Fig. 4

Temporal evolution of cortical activity during experimental sepsis. Alpha/delta ratio of the ECOG signal in sepsis vs. sham (a) and septic shock (b) group. No difference is observed in the sepsis and sham groups. There is a significant decrease in ADR in the septic shock group between T1SS and T4SS. Data are presented as median ± mean absolute deviation; *p < 0.05

Discussion

We formally demonstrate, in a clinically relevant animal model, that dCA, NVC, and cortical functions are impaired at the time of septic shock, supporting the hypothesis that SAE is, at least in part, a consequence of relative cerebral hypoperfusion.

Animal studies prior to this one concluded that CA was not altered in sepsis but only measured static CA (sCA) [4648], a finding that was in line with human studies [11, 19, 49]. Our findings are thus more in line with clinical studies that suggested that dCA is altered during sepsis [8, 9, 19, 20], particularly [8, 9] or exclusively [20] in patients with SAE. Of note, a dissociation of sCA and dCA has been also observed in other clinical settings, such in anesthetized or in stroke patients [50, 51]. Our model also minimizes chronic and acute confounders that were unavoidable in human studies and allows us to conclude that mechanisms of dCA are impaired per se at the time of septic shock. The longitudinal analysis indicates that dCA impairment is a dynamic process, as suggested by prior experiments with LPS infusion [19, 52, 53]. Both time-domain (Lxa) and frequency-domain (TFA) metrics yielded similar results, but TFA showed changes earlier than Lxa. Although experimental studies have shown a poor sensitivity of gain alone as indicator of autoregulatory performance, the concomitant reduction in the phase shift, associated with a significant coherence, makes this finding more reliable [54]. Nevertheless, no previous studies have compared Lxa and TFA performance in describing variations in autoregulation, and this question is beyond the scope of this work. We thus cannot draw any firm conclusion on the comparative sensitivity and specificity of both approaches.

As seemingly opposed to some human studies, however, the alteration in dCA occurred only after the onset of septic shock in our model. Again, we made this observation at controlled normal MAP levels in otherwise healthy animals, which strongly indicates an intrinsic alteration of dCA. Although we did not formally demonstrate it, this acute alteration probably indicates a narrowing of the plateau of the autoregulatory curve, rather than a shift in the overall curve [55]. On the other hand, clinical studies have shown that the ranges of the plateau of the autoregulatory curve are highly variable between individuals [56, 57], with elderly patients and those with a chronic hypertension demonstrating a right shift of the curve, i.e., elevated lower limit of the plateau [58, 59]. As age and pre-existing cerebrovascular disorders are also well-known risk factors of SAE [6062], it is thus possible that the alteration of CA in the less severe phases of sepsis observed in some studies [9, 20, 63] is due to a level of MAP below the lower limit of a right-shifted autoregulatory curve, rather than an alteration of CA per se. Of note, although LPS infusion does not fully recapitulate the pathophysiology of sepsis, an experimental study in healthy volunteers receiving LPS, which mimics the early phase of sepsis, did not demonstrate an alteration of CA [64]. It is also possible that patients with chronic cerebrovascular disorder might show earlier sensitivity to sepsis-induced alterations in dCA.

Whereas earlier studies assessed NVC in stimuli-induced conditions both in septic patients and animals models [22, 23], little is known about NVC during spontaneous brain activity. In contrast to these studies, which found a reduction in amplitude [22] and a delay [23] in the CBFv response to stimulus-induced cortical activity, we found no significant variations in the amplitude or in the time lag of the CBFv response, independently from the EEG frequency band assessed, even if a trend in the reduction of the CBFv response was observed when comparing the percentage of EEG peaks followed by a CBFv peak. These differences with previous studies could be due to the fact that the magnitude of spontaneous variations in cortical activity is not sufficient to challenge CBF regulation. However, an alteration in the coherence between cortical activity and CBFv was observed during septic shock, indicating a reduced efficiency of cerebral vessels to adjust CBF to spontaneous fluctuations of cortical activity.

Finally, alterations in cortical activity, as assessed by the ADR, also became evident at the time dCA and NVC were altered, after the onset of shock, and despite a MAP maintained within a normal range. This temporal sequence thus suggests that the pathophysiological mechanisms of CA and NVC impairment might be similar to those leading to systemic circulatory failure, such as general microvascular dysfunction [19]. These findings also indicate that the intrinsic alterations in the mechanisms of CBF homeostasis are indeed causing part of the cortical dysfunction associated with sepsis. Most studies on carbon dioxide-induced cerebral vasoreactivity in sepsis also confirm cerebral microcirculation failure [10, 65]. Other animal studies showed structural microcirculation changes induced by sepsis, such as the reduction in the proportion of cortical perfused vessels [7] probably attributable to endothelial adhesion of leucocytes and platelet [66], astrocyte end-feet [5], and pericytes [67] detachment from the vessel walls, and increased blood-brain barrier (BBB) permeability [4, 68] contributing to altered extracellular milieu of the brain and to disrupt the neurovascular unit. Previous studies suggested a prominent role of BBB dysfunction, mediated by cytokines such as TNF-α in SAE [4, 6, 69]. In humans, severe encephalopathy assessed by EEG was associated with higher CSF protein level of protein, suggestive of an increase in BBB permeability [70]. These structural changes at the endothelial and blood-brain barrier levels may be partly responsible for the functional cerebrovascular dysfunction we described. Furthermore, endothelin-1 contributes to CBF impairment by stimulating brain inflammation in sepsis [71]. Endothelin receptors antagonist have shown some promising results on microcirculation and mitochondrial dysfunction in sepsis [72, 73], and their effect on dCA and NVC could be further studied in our model.

Our study provides some leads for future clinical applications and studies. First, with the limitations discussed above, our results suggest that it could be possible to replace stimulus-induced assessment of NVC by analysis of the coherence of spontaneous fluctuation of CBF and neuronal activity. Since NVC reflects a physiologically complemental aspect of CBF regulation, it should be assessed as frequently as cerebral autoregulation, but the lack of standardized and automated protocol of analysis for critically ill patients limits the utility of stimulus-induced NVC assessment in clinical practice [74]. Further studies in humans are, therefore, necessary to evaluate feasibility and efficacy of non-stimulus-induced NVC assessment. Second, the observation that not only CA but also NCV is impaired during septic shock also raises the possibility that strategies aiming at optimizing MAP or even CA might not fully prevent the brain from injuries caused by loss of NVC. Structural changes potentially responsible for the neurovascular unit disruption, as discussed above, are not reversed by optimization of CPP. Further research should focus on strategies preventing or reversing neurovascular unit disruption (for example, reducing oxidative stress [74]) in order to preserve NVC function. Again, it would be required to assess NVC in the ICU. Finally, the integration of dCA and NVC concepts into prognostic and therapeutic approaches would improve the clinical application of these tools. This may guide future randomized trials in choosing the right therapeutic intervention (optimal target MAP therapies in patients with dCA alteration only and coupled therapies in those presenting NVC impairment too) in order to show if focusing on cerebral circulation improves care of septic patients, as it seemed to be the case in preliminary studies in other conditions [75, 76].

Our study presents some limitations. The laser Doppler technique has been widely employed to measure regional changes in CBF thanks to its high temporal resolution [23, 77]. However, this technique presents several limitations, not least the fact that it measures velocity rather than flow, it overestimate high increase in CBF in comparison with some reference methods [78], and absolute values are extremely heterogenous [79]; for this reason, results have to be interpreted cautiously. We followed some procedures to circumvent these limitations. The probe was secured in its initial position in order to prevent artifacts. Moreover, for each animal and for each time point, CBFv data were normalized and averaged across the two hemispheres, before calculation of Lx and TFA, both measures reflecting the relation between CBF and MAP fluctuations rather than absolute values. Second, it is well known that the pressure-flow relationship is nonlinear [31, 55] because of the variation in vascular resistance as a consequence of changes in MAP and the effect of other parameters, such as PaCO2, that might influence CBF. Since the complexity of most nonlinear methods precludes the physiological interpretation of the results [55], linear models are usually employed, and a lack of linearity between MAP and CBF in these models is interpreted as a normal CA [45]. A lack of linearity could also be the result of a low signal-to-noise ratio leading to a misinterpretation of data. In order to circumvent this issue, we estimated minimal meaningful coherence thresholds and excluded gain and phase unreliable results. Thus, our results should be robust and reliable. Moreover, there were no significant correlations between dCA parameters and PaCO2, ruling out the possibility that PaCO2 variations could have confounded dCA estimations. Third, previous studies examined the influence of sedation on dCA, showing that it is enhanced by midazolam and probably also by ketamine [80, 81], both of which were used in these experiments. However, although we cannot rule out the possibility that absolute dCA values might have been influenced by sedation, especially ketamine, we found no statistically significant differences between the sepsis and sham groups. Further, prolonged experiments, associated with an increasing cumulative amount of sedative drugs, disclosed a decrease in dCA. The effect of sedation on NVC at the moment is unclear. Fourth, high doses of NA can affect dCA [42]. A study in healthy volunteers has suggested that NA effect on cerebral vasculature might be partially due to increase in ventilation via a β-adrenergic stimulation of the carotid chemoreceptors [42]. Since animals were mechanically ventilated, NA could not influence ventilation frequency. So, as septic shock animals served as their own control and NA-induced PaCO2 variations were controlled by mechanical ventilation, the NA influence on CA assessment was probably limited. Finally, in order to limit for potential confounders, we did not employ specific sepsis therapies, such as antibiotics, since it has been shown that they can modify BBB [82], influence central nervous system inflammation [83, 84], and induce seizures [85]; on the other hand, this do not allow an entire translation of our results to clinical practice. Furthermore, albeit sheep is a promising surrogate for modelling human brain diseases [86], interspecies differences limit the generalization of animals studies results to humans.

Conclusions

In this clinically relevant model of sepsis, we observed a progressive loss of dCA and NVC, in septic shock, and this was associated with cortical neuronal dysfunction. These findings indicate that the alteration of mechanisms controlling cortical perfusion plays a role in the pathophysiology of SAE; both dCA and NVC should be assessed in clinical practice and therapies targeting only CA could not be efficacious to prevent neuronal dysfunction. NVC assessment without stimulation protocols could increase the employment of this tool in clinical practice. Further study should aim to clarify the molecular mechanisms of dCA and NVC alterations and to develop prognostic and therapeutic approaches as well.

Supplementary information

40635_2020_332_MOESM1_ESM.zip (298.3KB, zip)

Additional file 1. This section contains five additional figures and a word file with detailed Materials and Methods section and figure legends. Supplemental figure S1 provides a representation of power spectra of magnitude-squared coherence in sham group used in the neurovascular coupling analysis process, while supplemental figure S2 and S3 (a,b,c) provide additional results pertaining to neurovascular coupling analysis.

Acknowledgements

Not applicable.

Abbreviations

ADR

Alpha-delta ratio

BBB

Blood-brain barrier

BPU

Blood perfusion unit

CA

Cerebral autoregulation

sCA

Static cerebral autoregulation

dCA

Dynamic cerebral autoregulation

CBF

Cerebral blood flow

mCBF

Mean cerebral blood flow

CBFv

Cerebral blood flow velocity

CI

Cardiac index

CO

Cardiac output

CPP

Cerebral perfusion pressure

ECOG

Electrocorticography

EEG

Electroencephalogram

Envelope of the cortical high gamma activity

HR

Heart rate

IQR

Interquartile range

MAP

Mean arterial pressure

MPAP

Mean pulmonary arterial pressure

MSC

Magnitude-squared coherence

NA

Noradrenaline

NVC

Neurovascular coupling

PaCO2

Arterial carbon dioxide partial pressure

PaO2

Arterial oxygen partial pressure

PEEP

Positive end-expiratory pressure

SAE

Sepsis-associated encephalopathy

SS

Septic shock

TFA

Transfer function analysis

VLF

Very low frequencies

Authors’ contributions

N.G., F.S.T., and J.C. conceived the original idea and designed the model. L.F. and F.S. carried out the experiments. L.F. collected the data, performed the analytic calculations and interpretation, and wrote the manuscript directly supervised by N.G. All authors discussed the results, commented on the manuscript, and approved the final version to be published.

Funding

This work was supported by the Fonds Erasme pour la Recherche Médicale–Convention de Recherche d’Excellence and the Fonds National pour la Recherche Scientifique.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

The Institutional Review Board for Animal Care of the Free University of Brussels (Belgium) approved all experimental procedures, which were also in compliance with ARRIVE (Animal Research: Reporting in Vivo Experiments) guidelines. Care and handling of the animals were in accord with National Institutes of Health guidelines (Institute of Laboratory Animal Resources).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s40635-020-00332-0.

References

  • 1.Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol. 2012;8:557–566. doi: 10.1038/nrneurol.2012.183. [DOI] [PubMed] [Google Scholar]
  • 2.Sprung CL, Peduzzi PN, Shatney CH, Schein RH, Wilson MF, Sheagren JN, Hinshaw LB. Impact of encephalopathy on mortality in the sepsis syndrome. Crit Care Med. 1990;18:801–806. doi: 10.1097/00003246-199008000-00001. [DOI] [PubMed] [Google Scholar]
  • 3.Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787. doi: 10.1001/jama.2010.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.du Moulin GC, Paterson D, Hedley-Whyte J, Broitman SA. E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability. Brain Res. 1985;340:261–268. doi: 10.1016/0006-8993(85)90922-9. [DOI] [PubMed] [Google Scholar]
  • 5.Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D. Bennett ED (1999) Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci Lond Engl. 1979;96:461–466. doi: 10.1042/cs0960461. [DOI] [PubMed] [Google Scholar]
  • 6.Alexander JJ, Jacob A, Cunningham P, Hensley L, Quigg RJ. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008;52:447–456. doi: 10.1016/j.neuint.2007.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Taccone FS, Su F, Pierrakos C, He X, James S, Dewitte O, Vincent J-L, Backer DD. Cerebral microcirculation is impaired during sepsis: an experimental study. Crit Care. 2010;14:1–10. doi: 10.1186/cc9205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schramm P, Klein K, Falkenberg L, Berres M, Closhen D, Werhahn KJ, David M, Werner C, Engelhard K. Impaired cerebrovascular autoregulation in patients with severe sepsis and sepsis-associated delirium. Crit Care. 2012;16:R181. doi: 10.1186/cc11665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Crippa IA, Subirà C, Vincent J-L, Fernandez RF, Hernandez SC, Cavicchi FZ, Creteur J, Taccone FS. Impaired cerebral autoregulation is associated with brain dysfunction in patients with sepsis. Crit Care. 2018;22:327. doi: 10.1186/s13054-018-2258-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Taccone FS, Castanares-Zapatero D, Peres-Bota D, Vincent J-L, Berre’ J, Melot C (2010) Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 12:35–42 . 10.1007/s12028-009-9289-6 [DOI] [PubMed]
  • 11.Matta BF, Stow PJ. Sepsis-induced vasoparalysis does not involve the cerebral vasculature: indirect evidence from autoregulation and carbon dioxide reactivity studies. Br J Anaesth. 1996;76:790–794. doi: 10.1093/bja/76.6.790. [DOI] [PubMed] [Google Scholar]
  • 12.Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G. The neuropathology of septic shock. Brain Pathol Zurich Switz. 2004;14:21–33. doi: 10.1111/j.1750-3639.2004.tb00494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Heming N, Mazeraud A, Verdonk F, Bozza FA, Chrétien F, Sharshar T. Neuroanatomy of sepsis-associated encephalopathy. Crit Care. 2017;21:65. doi: 10.1186/s13054-017-1643-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia. 2007;55:1263–1271. doi: 10.1002/glia.20557. [DOI] [PubMed] [Google Scholar]
  • 15.Willie CK, Tzeng Y, Fisher JA, Ainslie PN. Integrative regulation of human brain blood flow. J Physiol. 2014;592:841–859. doi: 10.1113/jphysiol.2013.268953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.LASSEN NA (1959) Cerebral blood flow and oxygen consumption in man. Physiol Rev 39:183–238 [DOI] [PubMed]
  • 17.Birch AA, Dirnhuber MJ, Hartley-Davies R, Iannotti F, Neil-Dwyer G. Assessment of autoregulation by means of periodic changes in blood pressure. Stroke. 1995;26:834–837. doi: 10.1161/01.STR.26.5.834. [DOI] [PubMed] [Google Scholar]
  • 18.Schmidt B, Klingelhöfer J, Perkes I, Czosnyka M. Cerebral autoregulatory response depends on the direction of change in perfusion pressure. J Neurotrauma. 2009;26:651–656. doi: 10.1089/neu.2008.0784. [DOI] [PubMed] [Google Scholar]
  • 19.Berg RMG, Plovsing RR, Ronit A, Bailey DM, Holstein-Rathlou N-H, Møller K. Disassociation of static and dynamic cerebral autoregulatory performance in healthy volunteers after lipopolysaccharide infusion and in patients with sepsis. Am J Physiol-Regul Integr Comp Physiol. 2012;303:R1127–R1135. doi: 10.1152/ajpregu.00242.2012. [DOI] [PubMed] [Google Scholar]
  • 20.Pfister D, Siegemund M, Dell-Kuster S, Smielewski P, Rüegg S, Strebel SP, Marsch SC, Pargger H, Steiner LA. Cerebral perfusion in sepsis-associated delirium. Crit Care. 2008;12:1–9. doi: 10.1186/cc6891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent J-L, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801. doi: 10.1001/jama.2016.0287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rosengarten B, Krekel D, Kuhnert S, Schulz R. Early neurovascular uncoupling in the brain during community acquired pneumonia. Crit Care. 2012;16:1–8. doi: 10.1186/cc11310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rosengarten B, Hecht M, Auch D, Ghofrani HA, Schermuly RT, Grimminger F, Kaps M. Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats. Cerebrovasc Dis. 2006;23:140–147. doi: 10.1159/000097051. [DOI] [PubMed] [Google Scholar]
  • 24.Taccone FS, Su F, Deyne CD, Abdellhai A, Pierrakos C, He X, Donadello K, Dewitte O, Vincent J-L, Backer DD. Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis*. Crit Care Med. 2014;42:e114. doi: 10.1097/ccm.0b013e3182a641b8. [DOI] [PubMed] [Google Scholar]
  • 25.Berman A (2003) Effects of body surface area estimates on predicted energy requirements and heat stress. J Dairy Sci 86:3605–3610 . 10.3168/jds.S0022-0302(03)73966-6 [DOI] [PubMed]
  • 26.Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795–1815. doi: 10.1007/s00134-014-3525-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zeiler FA, Donnelly J, Cardim D, Menon DK, Smielewski P, Czosnyka M. ICP versus laser Doppler cerebrovascular reactivity indices to assess brain autoregulatory capacity. Neurocrit Care. 2018;28:194–202. doi: 10.1007/s12028-017-0472-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brady KM, Lee JK, Kibler KK, Smielewski P, Czosnyka M, Easley RB, Koehler RC, Shaffner DH. Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy. Stroke. 2007;38:2818–2825. doi: 10.1161/STROKEAHA.107.485706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lam JM, Hsiang JN, Poon WS. Monitoring of autoregulation using laser Doppler flowmetry in patients with head injury. J Neurosurg. 1997;86:438–445. doi: 10.3171/jns.1997.86.3.0438. [DOI] [PubMed] [Google Scholar]
  • 30.Cerebral Autoregulation Research Network.http://www.car-net.org/content/resources. Accessed 2 June 20.
  • 31.Zhang R, Zuckerman JH, Giller CA, Levine BD. Transfer function analysis of dynamic cerebral autoregulation in humans. Am J Physiol. 1998;274:H233–H241. doi: 10.1152/ajpheart.1998.274.1.H233. [DOI] [PubMed] [Google Scholar]
  • 32.Panerai RB. Cerebral autoregulation: from models to clinical applications. Cardiovasc Eng. 2007;8:42–59. doi: 10.1007/s10558-007-9044-6. [DOI] [PubMed] [Google Scholar]
  • 33.Saka (2010) Linear superposition of sensory-evoked and ongoing cortical hemodynamics. Front Neuroenergetics. 10.3389/fnene.2010.00023 [DOI] [PMC free article] [PubMed]
  • 34.Bergel A, Deffieux T, Demené C, Tanter M, Cohen I. Local hippocampal fast gamma rhythms precede brain-wide hyperemic patterns during spontaneous rodent REM sleep. Nat Commun. 2018;9:5364. doi: 10.1038/s41467-018-07752-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bruyns-Haylett M, Harris S, Boorman L, Zheng Y, Berwick J, Jones M. The resting-state neurovascular coupling relationship: rapid changes in spontaneous neural activity in the somatosensory cortex are associated with haemodynamic fluctuations that resemble stimulus-evoked haemodynamics. Eur J Neurosci. 2013;38:2902–2916. doi: 10.1111/ejn.12295. [DOI] [PubMed] [Google Scholar]
  • 36.Novak P. Lepicovska V. Slow modulation of EEG: NeuroReport. 1992;3:189–192. doi: 10.1097/00001756-199202000-00017. [DOI] [PubMed] [Google Scholar]
  • 37.Novak P, Lepicovska V, Dostalek C (1992) Periodic amplitude modulation of EEG. Neurosci Lett 136:213–215 . 10.1016/0304-3940(92)90051-8 [DOI] [PubMed]
  • 38.Admiraal MM, Gilmore EJ, Van Putten MJAM, Zaveri HP, Hirsch LJ. Gaspard N. Disruption of brain–heart coupling in sepsis: J Clin Neurophysiol. 2017;34:413–420. doi: 10.1097/WNP.0000000000000381. [DOI] [PubMed] [Google Scholar]
  • 39.Colgin LL, Denninger T, Fyhn M, Hafting T, Bonnevie T, Jensen O, Moser M-B, Moser EI. Frequency of gamma oscillations routes flow of information in the hippocampus. Nature. 2009;462:353–357. doi: 10.1038/nature08573. [DOI] [PubMed] [Google Scholar]
  • 40.Zhang Z, Khatami R. Predominant endothelial vasomotor activity during human sleep: a near-infrared spectroscopy study. Eur J Neurosci. 2014;40:3396–3404. doi: 10.1111/ejn.12702. [DOI] [PubMed] [Google Scholar]
  • 41.Bosch BM, Bringard A, Ferretti G, Schwartz S, Iglói K. Effect of cerebral vasomotion during physical exercise on associative memory, a near-infrared spectroscopy study. Neurophotonics. 2017;4:041404. doi: 10.1117/1.NPh.4.4.041404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Berg RM, Plovsing RR, Bailey DM, Holstein-Rathlou N-H, Møller K. The dynamic cerebral autoregulatory adaptive response to noradrenaline is attenuated during systemic inflammation in humans. Clin Exp Pharmacol Physiol. 2015;42:740–746. doi: 10.1111/1440-1681.12421. [DOI] [PubMed] [Google Scholar]
  • 43.Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B: Methodological:289–300. 10.2307/2346101
  • 44.Giller CA (1990) The frequency-dependent behavior of cerebral autoregulation: Neurosurgery 27:362–368. 10.1227/00006123-199009000-00004 [DOI] [PubMed]
  • 45.Claassen JA, Abeelen ASM den, Simpson DM, Panerai RB, (CAet) on behalf of the international CARN (2016) Transfer function analysis of dynamic cerebral autoregulation: a white paper from the International Cerebral Autoregulation Research Network. J Cereb Blood Flow Metab 36:665–680 . 10.1177/0271678x15626425 [DOI] [PMC free article] [PubMed]
  • 46.Pedersen M, Brandt CT, Knudsen GM, Østergaard C, Skinhøj P, Skovsted IC, Frimodt-Møller N, Møller K. The effect of S. Pneumoniae bacteremia on cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab. 2008;28:126–134. doi: 10.1038/sj.jcbfm.9600514. [DOI] [PubMed] [Google Scholar]
  • 47.Takala J, Booke M, Westphal M, Hinder F, Traber LD, Traber DL (2003) Cerebral blood flow is not altered in sheep with Pseudomonas aeruginosa sepsis treated with norepinephrine or nitric oxide synthase inhibition. Anesth Analg 96:1122–1128, table of contents [DOI] [PubMed]
  • 48.Rosengarten B, Hecht M, Wolff S, Kaps M. Autoregulative function in the brain in an endotoxic rat shock model. Inflamm Res. 2008;57:542–546. doi: 10.1007/s00011-008-7199-2. [DOI] [PubMed] [Google Scholar]
  • 49.Smith SM, Padayachee S, Modaresi KB, Smithies MN, Bihari DJ (1998) Cerebral blood flow is proportional to cardiac index in patients with septic shock. J Crit Care 13:104–109 . 10.1016/S0883-9441(98)90013-2 [DOI] [PubMed]
  • 50.Dawson SL, Blake MJ, Panerai RB, Potter JF. Dynamic but not static cerebral autoregulation is impaired in acute ischaemic stroke. Cerebrovasc Dis. 2000;10:126–132. doi: 10.1159/000016041. [DOI] [PubMed] [Google Scholar]
  • 51.Strebel S, Lam A, Matta B, Mayberg TS, Aaslid R, Newell DW (1995) Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia: Anesthesiology 83:66–76. 10.1097/00000542-199507000-00008 [DOI] [PubMed]
  • 52.Andreasen A, Krabbe K, Krogh-Madsen R, Taudorf S, Pedersen B, Moller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem. 2008;15:1697–1705. doi: 10.2174/092986708784872393. [DOI] [PubMed] [Google Scholar]
  • 53.Berg RMG, Plovsing RR, Bailey DM, Holstein-Rathlou N-H, Møller K. Dynamic cerebral autoregulation to induced blood pressure changes in human experimental and clinical sepsis. Clin Physiol Funct Imaging. 2016;36:490–496. doi: 10.1111/cpf.12256. [DOI] [PubMed] [Google Scholar]
  • 54.Govindan RB, Brady KM, Massaro AN, Perin J, Jennings JM, DuPlessis AJ, Koehler RC, Lee JK. Comparison of frequency- and time-domain autoregulation and vasoreactivity indices in a piglet model of hypoxia-ischemia and hypothermia. Dev Neurosci. 2018;40:547–559. doi: 10.1159/000499425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Tan CO. Defining the characteristic relationship between arterial pressure and cerebral flow. J Appl Physiol. 2012;113:1194–1200. doi: 10.1152/japplphysiol.00783.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Joshi B, Ono M, Brown C, Brady K, Easley RB, Yenokyan G, Gottesman RF. Hogue CW. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass: Anesth Analg. 2012;114:503–510. doi: 10.1213/ANE.0b013e31823d292a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Hori D, Brown C, Ono M, Rappold T, Sieber F, Gottschalk A, Neufeld KJ, Gottesman R, Adachi H, Hogue CW. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth. 2014;113:1009–1017. doi: 10.1093/bja/aeu319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke. 2010;41:2697–2704. doi: 10.1161/STROKEAHA.110.594168. [DOI] [PubMed] [Google Scholar]
  • 59.Gao Y, Zhang M, Han Q, Li W, Xin Q, Wang Y, Li Z. Cerebral autoregulation in response to posture change in elderly subjects-assessment by wavelet phase coherence analysis of cerebral tissue oxyhemoglobin concentrations and arterial blood pressure signals. Behav Brain Res. 2015;278:330–336. doi: 10.1016/j.bbr.2014.10.019. [DOI] [PubMed] [Google Scholar]
  • 60.Eames PJ, Blake MJ, Dawson SL, Panerai RB, Potter JF. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2002;72:467–472. doi: 10.1136/jnnp.72.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil A-S, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit J-F. Potentially modifiable factors contributing to sepsis-associated encephalopathy. Intensive Care Med. 2017;43:1075–1084. doi: 10.1007/s00134-017-4807-z. [DOI] [PubMed] [Google Scholar]
  • 62.Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161–192. [PubMed] [Google Scholar]
  • 63.Steiner LA, Pfister D, Strebel SP, Radolovich D, Smielewski P, Czosnyka M. Near-infrared spectroscopy can monitor dynamic cerebral autoregulation in adults. Neurocrit Care. 2009;10:122–128. doi: 10.1007/s12028-008-9140-5. [DOI] [PubMed] [Google Scholar]
  • 64.Berg RM, Plovsing RR, Evans KA, Christiansen CB, Bailey DM, Holstein-Rathlou N-H, Møller K. Lipopolysaccharide infusion enhances dynamic cerebral autoregulation without affecting cerebral oxygen vasoreactivity in healthy volunteers. Crit Care. 2013;17:R238. doi: 10.1186/cc13062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Terborg C, Schummer W, Albrecht M, Reinhart K, Weiller C, Röther J. Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med. 2001;27:1231–1234. doi: 10.1007/s001340101005. [DOI] [PubMed] [Google Scholar]
  • 66.Vachharajani V, Russell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall J, Granger DN. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation. 2010;12:183–194. doi: 10.1080/10739680590904982. [DOI] [PubMed] [Google Scholar]
  • 67.Nishioku T, Dohgu S, Takata F, Eto T, Ishikawa N, Kodama KB, Nakagawa S, Yamauchi A, Kataoka Y. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood–brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol Neurobiol. 2009;29:309–316. doi: 10.1007/s10571-008-9322-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Sharshar T, Hopkinson NS, Orlikowski D, Annane D. The brain in sepsis – culprit and victim. Crit Care. 2004;9:37. doi: 10.1186/cc2951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Papadopoulos MC, Davies DC, Moss RF, Tighe D. Bennett ED. Pathophysiology of septic encephalopathy: a review: Crit Care Med. 2000;28:3019–3024. doi: 10.1097/00003246-200008000-00057. [DOI] [PubMed] [Google Scholar]
  • 70.Young GB, Bolton CF, Archibald YM, Austin TW. Wells GA. The electroencephalogram in sepsis-associated encephalopathy: J Clin Neurophysiol. 1992;9:145–152. doi: 10.1097/00004691-199201000-00016. [DOI] [PubMed] [Google Scholar]
  • 71.van Gool WA, van de Beek D, Eikelenboom P (2010) Systemic infection and delirium: when cytokines and acetylcholine collide. The Lancet 375:773–775 . 10.1016/S0140-6736(09)61158-2 [DOI] [PubMed]
  • 72.Rutai A, Fejes R, Juhász L, Tallósy SP, Poles MZ, Földesi I, Mészáros AT, Szabó A, Boros M, Kaszaki J (2019) Endothelin A and B receptors: potential targets for microcirculatory-mitochondrial therapy in experimental sepsis. SHOCK 1. 10.1097/SHK.0000000000001414 [DOI] [PubMed]
  • 73.Naito Y, Yoshioka K, Tanaka K, Tatsumi K, Kimura S, Kasuya Y. Endothelin B receptor-mediated encephalopathic events in mouse sepsis model. Life Sci. 2014;118:340–346. doi: 10.1016/j.lfs.2014.03.012. [DOI] [PubMed] [Google Scholar]
  • 74.Phillips AA, Chan FH, Zheng M, Krassioukov AV, Ainslie PN (2015) Neurovascular coupling in humans: physiology, methodological advances and clinical implications. J Cereb Blood Flow Metab 0271678X15617954. 10.1177/0271678x15617954 [DOI] [PMC free article] [PubMed]
  • 75.Ono M, Arnaoutakis GJ, Fine DM, Brady K, Easley RB, Zheng Y, Brown C, Katz NM, Grams ME, Hogue CW (2013) Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury*: Crit Care Med 41:464–471. 10.1097/CCM.0b013e31826ab3a1 [DOI] [PMC free article] [PubMed]
  • 76.Aries MJH, Czosnyka M, Budohoski KP, Steiner LA, Lavinio A, Kolias AG, Hutchinson PJ, Brady KM, Menon DK, Pickard JD, Smielewski P (2012) Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury*: Crit Care Med 40:2456–2463. 10.1097/CCM.0b013e3182514eb6 [DOI] [PubMed]
  • 77.Florence G, Seylaz J. Rapid autoregulation of cerebral blood flow: a laser-Doppler flowmetry study. J Cereb Blood Flow Metab. 1992;12:674–680. doi: 10.1038/jcbfm.1992.92. [DOI] [PubMed] [Google Scholar]
  • 78.Fabricius M, Lauritzen M. Laser-Doppler evaluation of rat brain microcirculation: comparison with the [ 14 C]-iodoantipyrine method suggests discordance during cerebral blood flow increases. J Cereb Blood Flow Metab. 1996;16:156–161. doi: 10.1097/00004647-199601000-00018. [DOI] [PubMed] [Google Scholar]
  • 79.Dirnagl U, Kaplan B, Jacewicz M, Pulsinelli W. Continuous measurement of cerebral cortical blood flow by laser—Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab. 1989;9:589–596. doi: 10.1038/jcbfm.1989.84. [DOI] [PubMed] [Google Scholar]
  • 80.Ogawa Y, Iwasaki K, Aoki K, Gokan D, Hirose N, Kato J. Ogawa S. The different effects of midazolam and propofol sedation on dynamic cerebral autoregulation: Anesth Analg. 2010;111:1279–1284. doi: 10.1213/ANE.0b013e3181f42fc0. [DOI] [PubMed] [Google Scholar]
  • 81.Engelhard K, Werner C, Möllenberg O, Kochs E. S(+)-ketamine/propofol maintain dynamic cerebrovascular autoregulation in humans. Can J Anesth Can Anesth. 2001;48:1034–1039. doi: 10.1007/BF03016597. [DOI] [PubMed] [Google Scholar]
  • 82.Wu Q, Zhang Y, Zhang Y, Xia C, Lai Q, Dong Z, Kuang W, Yang C, Su D, Li H, Zhong Z (2020) Potential effects of antibiotic-induced gut microbiome alteration on blood–brain barrier permeability compromise in rhesus monkeys. Ann N Y Acad Sci nyas.14312. 10.1111/nyas.14312 [DOI] [PubMed]
  • 83.Adembri C, Selmi V, Vitali L, Tani A, Margheri M, Loriga B, Carlucci M, Nosi D, Formigli L, De Gaudio AR (2014) Minocycline but not tigecycline is neuroprotective and reduces the neuroinflammatory response induced by the superimposition of sepsis upon traumatic brain injury*: Crit Care Med 42:e570–e582. 10.1097/CCM.0000000000000414 [DOI] [PubMed]
  • 84.Melzer N, Meuth SG, Torres-Salazar D, Bittner S, Zozulya AL, Weidenfeller C, Kotsiari A, Stangel M, Fahlke C, Wiendl H. A β-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS ONE. 2008;3:e3149. doi: 10.1371/journal.pone.0003149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis. 2005;24:649–653. doi: 10.1007/s10096-005-0021-y. [DOI] [PubMed] [Google Scholar]
  • 86.Kaiser E, West F. Large animal ischemic stroke models: replicating human stroke pathophysiology. Neural Regen Res. 2020;15:1377. doi: 10.4103/1673-5374.274324. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

40635_2020_332_MOESM1_ESM.zip (298.3KB, zip)

Additional file 1. This section contains five additional figures and a word file with detailed Materials and Methods section and figure legends. Supplemental figure S1 provides a representation of power spectra of magnitude-squared coherence in sham group used in the neurovascular coupling analysis process, while supplemental figure S2 and S3 (a,b,c) provide additional results pertaining to neurovascular coupling analysis.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Intensive Care Medicine Experimental are provided here courtesy of Springer-Verlag

RESOURCES